Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the

Dow Jones Industrial Average

(

^DJI

) trading down 153.49 points (-0.9%) at 16,461 as of Wednesday, Oct. 22, 2014, 4:35 PM ET. The NYSE advances/declines ratio sits at 2,410 issues advancing vs. 704 declining with 100 unchanged.

The Chemicals industry as a whole closed the day up 1.3% versus the S&P 500, which was down 0.7%. Top gainers within the Chemicals industry included

Methes Energies International

(

MEIL

), up 6.0%,

Ceres

(

CERE

), up 6.9%,

Metabolix

(

MBLX

), up 3.2%,

Synthesis Energy Sys

(

SYMX

), up 3.4% and

Gevo

(

GEVO

), up 3.7%.

TheStreet Ratings Group would like to highlight 3 stocks pushing the industry higher today:

Synthesis Energy Sys

(

SYMX

) is one of the companies that pushed the Chemicals industry higher today. Synthesis Energy Sys was up $0.03 (3.4%) to $1.01 on light volume. Throughout the day, 123,836 shares of Synthesis Energy Sys exchanged hands as compared to its average daily volume of 345,600 shares. The stock ranged in a price between $0.97-$1.05 after having opened the day at $0.97 as compared to the previous trading day's close of $0.98.

Synthesis Energy Systems, Inc., a development stage energy and gasification technology company, provides various proprietary gasification technology systems and solutions to the energy and chemical industries worldwide. Synthesis Energy Sys has a market cap of $68.5 million and is part of the basic materials sector. Shares are up 62.8% year-to-date as of the close of trading on Wednesday. Currently there are no analysts who rate Synthesis Energy Sys a buy, no analysts rate it a sell, and none rate it a hold.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings rates Synthesis Energy Sys as a

sell

. The area that we feel has been the company's primary weakness has been its disappointing return on equity.

Highlights from TheStreet Ratings analysis on SYMX go as follows:

  • Current return on equity exceeded its ROE from the same quarter one year prior. This is a clear sign of strength within the company. Compared to other companies in the Energy Equipment & Services industry and the overall market, SYNTHESIS ENERGY SYSTEMS INC's return on equity significantly trails that of both the industry average and the S&P 500.
  • Net operating cash flow has increased to -$2.35 million or 10.48% when compared to the same quarter last year. In addition, SYNTHESIS ENERGY SYSTEMS INC has also vastly surpassed the industry average cash flow growth rate of -75.34%.
  • SYMX's debt-to-equity ratio is very low at 0.04 and is currently below that of the industry average, implying that there has been very successful management of debt levels. To add to this, SYMX has a quick ratio of 1.93, which demonstrates the ability of the company to cover short-term liquidity needs.
  • This stock has increased by 34.72% over the past year, outperforming the rise in the S&P 500 Index during the same period. Regarding the future course of this stock, we feel that the risks involved in investing in SYMX do not compensate for any future upside potential, despite the fact that it has seen nice gains over the past 12 months.
  • SYNTHESIS ENERGY SYSTEMS INC has improved earnings per share by 33.3% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. During the past fiscal year, SYNTHESIS ENERGY SYSTEMS INC continued to lose money by earning -$0.21 versus -$0.34 in the prior year.

You can view the full analysis from the report here:

Synthesis Energy Sys Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

At the close,

Metabolix

(

MBLX

) was up $0.02 (3.2%) to $0.76 on light volume. Throughout the day, 102,982 shares of Metabolix exchanged hands as compared to its average daily volume of 194,800 shares. The stock ranged in a price between $0.74-$0.77 after having opened the day at $0.74 as compared to the previous trading day's close of $0.73.

Metabolix, Inc., a bioscience company, focuses on delivering sustainable solutions to the plastics and chemicals industries. It produces a family of biopolymers found in nature called polyhydroxyalkanoates, which occur naturally in living organisms and are chemically similar to polyesters. Metabolix has a market cap of $61.7 million and is part of the basic materials sector. Shares are down 42.5% year-to-date as of the close of trading on Wednesday. Currently there are no analysts who rate Metabolix a buy, no analysts rate it a sell, and 2 rate it a hold.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings rates Metabolix as a

sell

. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity and generally disappointing historical performance in the stock itself.

Highlights from TheStreet Ratings analysis on MBLX go as follows:

  • Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness within the corporation. Compared to other companies in the Chemicals industry and the overall market, METABOLIX INC's return on equity significantly trails that of both the industry average and the S&P 500.
  • MBLX's stock share price has done very poorly compared to where it was a year ago: Despite any rallies, the net result is that it is down by 37.07%, which is also worse that the performance of the S&P 500 Index. Investors have so far failed to pay much attention to the earnings improvements the company has managed to achieve over the last quarter. Naturally, the overall market trend is bound to be a significant factor. However, in one sense, the stock's sharp decline last year is a positive for future investors, making it cheaper (in proportion to its earnings over the past year) than most other stocks in its industry. But due to other concerns, we feel the stock is still not a good buy right now.
  • The revenue fell significantly faster than the industry average of 9.3%. Since the same quarter one year prior, revenues fell by 31.4%. The declining revenue has not hurt the company's bottom line, with increasing earnings per share.
  • METABOLIX INC has improved earnings per share by 8.7% in the most recent quarter compared to the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, METABOLIX INC swung to a loss, reporting -$0.88 versus $0.10 in the prior year. This year, the market expects an improvement in earnings (-$0.83 versus -$0.88).
  • The net income growth from the same quarter one year ago has exceeded that of the S&P 500 and the Chemicals industry average. The net income increased by 8.0% when compared to the same quarter one year prior, going from -$7.87 million to -$7.24 million.

You can view the full analysis from the report here:

Metabolix Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Ceres

(

CERE

) was another company that pushed the Chemicals industry higher today. Ceres was up $0.02 (6.9%) to $0.38 on heavy volume. Throughout the day, 283,450 shares of Ceres exchanged hands as compared to its average daily volume of 172,700 shares. The stock ranged in a price between $0.34-$0.38 after having opened the day at $0.34 as compared to the previous trading day's close of $0.36.

Ceres, Inc., an agricultural biotechnology company, develops and sells energy crops to produce renewable bioenergy feedstocks in North America. Ceres has a market cap of $16.4 million and is part of the basic materials sector. Shares are down 75.3% year-to-date as of the close of trading on Wednesday. Currently there are 2 analysts who rate Ceres a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Ceres as a

sell

. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity and generally disappointing historical performance in the stock itself.

Highlights from TheStreet Ratings analysis on CERE go as follows:

  • Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness within the corporation. Compared to other companies in the Oil, Gas & Consumable Fuels industry and the overall market, CERES INC's return on equity significantly trails that of both the industry average and the S&P 500.
  • CERE's stock share price has done very poorly compared to where it was a year ago: Despite any rallies, the net result is that it is down by 82.11%, which is also worse that the performance of the S&P 500 Index. Investors have so far failed to pay much attention to the earnings improvements the company has managed to achieve over the last quarter. Naturally, the overall market trend is bound to be a significant factor. However, in one sense, the stock's sharp decline last year is a positive for future investors, making it cheaper (in proportion to its earnings over the past year) than most other stocks in its industry. But due to other concerns, we feel the stock is still not a good buy right now.
  • The revenue fell significantly faster than the industry average of 3.2%. Since the same quarter one year prior, revenues fell by 40.5%. The declining revenue has not hurt the company's bottom line, with increasing earnings per share.
  • CERES INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, CERES INC reported poor results of -$1.31 versus -$1.22 in the prior year. This year, the market expects an improvement in earnings (-$0.61 versus -$1.31).
  • The net income growth from the same quarter one year ago has exceeded that of the S&P 500, but is less than that of the Oil, Gas & Consumable Fuels industry average. The net income increased by 17.1% when compared to the same quarter one year prior, going from -$9.32 million to -$7.73 million.

You can view the full analysis from the report here:

Ceres Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.